Axxam Receives US Patent for Innovative Technology Photina®

Axxam is pleased to announce the award of US Patent number US 7,601,805 B2, entitled “Photoprotein with improved bioluminescence”, describing the company’s proprietary photoprotein known as Photina®. The invention provides a chimeric photoprotein with improved luminescent activity and its use as a calcium indicator in reporter gene systems and in cell-based assays for the detection and measurement of intracellular calcium. This novel calcium-detecting photoprotein is applicable to a large number of different screening platforms for the pharmaceutical industry and for the study of any biological process involving calcium release.